1. A low repair endotype is predictive for response to FGF-18 treatment: data from the phase II oa forward study. (April 2021) Authors: Bay-Jensen, A.-C; Manginelli, A.; Karsdal, M.A.; Luo, Y.; He, Y.; Michaelis, M.; Guehring, H.; Ladel, C. Journal: Osteoarthritis and cartilage Issue: Volume 29(2021)Supplement 1 Page Start: S144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of cartilage markers in synovial fluid from the forward study provide insight to the biphasic effect of sprifermin. Issue 1 (April 2020) Authors: Bay-Jensen, A.-C.; Manginelli, A.; Moreau, F.; He, Y.; Luo, Y.; Bihlet, A.; Andersen, J.R.; Karsdal, M.A.; Guehring, H.; Ladel, C. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020)supplement Page Start: S496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0189 ASSESSMENT OF CARTILAGE DEGRADATION AND PROTECTIVE MARKERS IN SYNOVIAL FLUID FROM OSTEOARTHRITIS PATIENTS BEFORE AND AFTER CYCLES OF INTRA-ARTICULAR INJECTIONS WITH SPRIFERMIN. (2nd June 2020) Authors: Bay-Jensen, A. C.; Manginelli, A.; Moreau, F.; He, Y.; Luo, Y.; Andersen, J. R.; Bihlet, A. R.; Karsdal, M.; Gühring, H.; Ladel, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗